Literature DB >> 18195025

Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.

Neil K Fennelly1, Federico Sisti, Sarah C Higgins, Pádraig J Ross, Han van der Heide, Frits R Mooi, Aoife Boyd, Kingston H G Mills.   

Abstract

Certain bacteria use a type III secretion system (TTSS) to deliver effector proteins that interfere with cell function into host cells. While transcription of genes encoding TTSS components has been demonstrated, studies to date have failed to identify TTSS effector proteins in Bordetella pertussis. Here we present the first evidence of a functionally active TTSS in B. pertussis. Three known TTSS effectors, Bsp22, BopN, and BopD, were identified as TTSS substrates in B. pertussis 12743. We found expression of Bsp22 in a significant proportion of clinical isolates but not in common laboratory-adapted strains of B. pertussis. We generated a TTSS mutant of B. pertussis 12743 and showed that it induced significantly lower respiratory tract colonization in mice than the wild-type bacteria. Respiratory infection of mice with the mutant bacteria induced significantly greater innate proinflammatory cytokine production in the lungs soon after challenge, and this correlated with significantly higher antigen-specific interleukin-17, gamma interferon, and immunoglobulin G responses later in infection. Our findings suggest that the TTSS subverts innate and adaptive immune responses during infection of the lungs and may be a functionally important virulence factor for B. pertussis infection of humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18195025      PMCID: PMC2258832          DOI: 10.1128/IAI.00836-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Characterization of the type III secretion locus of Bordetella pertussis.

Authors:  A Fauconnier; A Veithen; P Gueirard; R Antoine; L Wacheul; C Locht; A Bollen; E Godfroid
Journal:  Int J Med Microbiol       Date:  2001-03       Impact factor: 3.473

2.  Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis.

Authors:  D Hot; R Antoine; G Renauld-Mongénie; V Caro; B Hennuy; E Levillain; L Huot; G Wittmann; D Poncet; F Jacob-Dubuisson; C Guyard; F Rimlinger; L Aujame; E Godfroid; N Guiso; M-J Quentin-Millet; Y Lemoine; C Locht
Journal:  Mol Genet Genomics       Date:  2003-05-24       Impact factor: 3.291

Review 3.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

4.  Serological study of Bordetella pertussis and related species.

Authors:  G ELDERING; C HORNBECK; J BAKER
Journal:  J Bacteriol       Date:  1957-08       Impact factor: 3.490

5.  Studies on Haemophilus pertussis. V. Relation between the phase of bacilli and the progress of the whooping-cough.

Authors:  T KASUGA; Y NAKASE; K UKISHIMA; K TAKATSU
Journal:  Kitasato Arch Exp Med       Date:  1954-09

6.  Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation.

Authors:  Annette Reissinger; Jason A Skinner; Ming H Yuk
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

7.  In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence.

Authors:  Greg A Somerville; Stephen B Beres; J Ross Fitzgerald; Frank R DeLeo; Robert L Cole; Jessica S Hoff; James M Musser
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

8.  Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system.

Authors:  M H Yuk; E T Harvill; P A Cotter; J F Miller
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

Review 9.  How best to estimate the global burden of pertussis?

Authors:  N S Crowcroft; C Stein; P Duclos; M Birmingham
Journal:  Lancet Infect Dis       Date:  2003-07       Impact factor: 25.071

Review 10.  The virulence plasmid of Yersinia, an antihost genome.

Authors:  G R Cornelis; A Boland; A P Boyd; C Geuijen; M Iriarte; C Neyt; M P Sory; I Stainier
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more
  43 in total

1.  Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica.

Authors:  Tracy L Nicholson; Anne M Buboltz; Eric T Harvill; Susan L Brockmeier
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

2.  Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality.

Authors:  M E Gaillard; D Bottero; C E Castuma; L A Basile; D Hozbor
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

3.  Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Laura S Weyrich; Eric T Harvill
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

4.  A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.

Authors:  A Dunne; L A Mielke; A C Allen; C E Sutton; R Higgs; C C Cunningham; S C Higgins; K H G Mills
Journal:  Mucosal Immunol       Date:  2014-10-15       Impact factor: 7.313

Review 5.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

Review 6.  Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.

Authors:  Dorji Dorji; Frits Mooi; Osvaldo Yantorno; Rajendar Deora; Ross M Graham; Trilochan K Mukkur
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

7.  Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice.

Authors:  V Wu; A A Smith; H You; T A Nguyen; R Ferguson; M Taylor; J E Park; P Llontop; K R Youngman; T Abramson
Journal:  Mucosal Immunol       Date:  2015-10-14       Impact factor: 7.313

Review 8.  Virulence factor secretion and translocation by Bordetella species.

Authors:  Ruchi Shrivastava; Jeff F Miller
Journal:  Curr Opin Microbiol       Date:  2009-01-29       Impact factor: 7.934

9.  IL-17 and anti-bacterial immunity: protection versus tissue damage.

Authors:  Andrea M Cooper
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

10.  Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN.

Authors:  Kanna Nagamatsu; Asaomi Kuwae; Tadashi Konaka; Shigenori Nagai; Sei Yoshida; Masahiro Eguchi; Mineo Watanabe; Hitomi Mimuro; Shigeo Koyasu; Akio Abe
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.